↓ Skip to main content

Dove Medical Press

Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial

Overview of attention for article published in Drug Design, Development and Therapy, July 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
43 Mendeley